Express Press Release Distribution

Accounting
Advertising
Aerospace
Agriculture
Apparel & Fashion
Automotive
Biotech
Chemicals
Computers
Construction
Consumer Services
Defense
Education
Electronics
Energy
Entertainment
Environment
Financial
Food & Beverage
Government
Healthcare
Human Resources
Industrial
International Trade
Internet & Online
Law
Management
Marketing
Media
Non Profit
Pharmaceuticals
Real Estate
Retail
Semiconductors
Small Business
Software
Sports
Telecommunications
Transportation / Logistics
Travel

EPR Archived News

Archived News 2012
~ April
~ March
~ February
~ January

Archived News 2011
~ December
~ November
~ October
~ September
~ August
~ July
~ June
~ May
~ April
~ March
~ February
~ January

Archived News 2010
Archived News 2009
Archived News 2008
Archived News 2007
Archived News 2006
Archived News 2005
Archived News 2004

 

Special Panel to be Held this Year`s Protein Kinases in Drug Discovery Conference

Released on = April 12, 2007, 3:14 pm

Press Release Author = GTCbio

Industry = Pharmaceuticals

Press Release Summary = Panel discussion at GTCbio\'s Protein Kinases in Drug
Discovery Conference

Press Release Body = MONROVIA, CA - At this year’s Protein Kinases in Drug Discovery
conference organized by GTCbio, a special panel of researchers will assemble to
discuss the challenges and progress associated with the inhibition of kinases in
chronic and acute disorders.

The panel will review the advantages and disadvantages for treating different
disorders and look into whether the inhibition of kinases is really a viable path
towards treating these disorders. The clinical issues related to inhibition will
also be covered by the panelists.

Among the panelists is Dr. Jessie English, Director of Kinase Center of Emphasis at
Pfizer, Dr. Andrew West, Instructor at the Department of Neurology at Johns Hopkins
University, Dr. Sridhar Rabindran, Associate Director of Oncology Research at Wyeth
Research and Dr. Maria Webb, Vice President of Preclinical Research, Biological &
Pharmacological Sciences at Pharmacopeia. Moderating the panel is Dr. Paul Jackson,
Team Leader of CNS Research at Johnson & Johnson.

The 2nd Protein Kinases in Drug Discovery conference will take place on May 31 –
June 1, 2007 at the Omni Parker House Hotel in Boston, Massachusetts. Additional
topics to be covered include Technologies for Identifying Kinase Targets and
Inhibitors, Kinase Targets and Inhibitors in Oncology, CNS, and Inflammatory
Disorders.

Among the prestigious organization to present are Pfizer, Merck, Johnson & Johnson,
Wyeth, GlaxoSmithKline, Eli Lilly, Bristol Myers Squibb, Genentech, AstraZeneca,
Schering-Plough, Abbott Laboratories, Boehringer Ingelheim, Amgen, MIT, Johns
Hopkins University, Harvard University, and the National Cancer Institute of the
National Institutes of Health.

For more information including a detailed agenda, exhibitor opportunities and
registration information visit
http://www.gtcbio.com/conference/conferenceDetails.aspx?id

Web Site = http://www.gtcbio.com

Contact Details = GTCBIO (626) 256-6405, (626) 256-6460 fax, raniah@gtcbio.com

  • Printer Friendly Format
  • Back to previous page...
  • Back to home page...
  • Submit your press releases...
  •